H19 inhibition increases HDAC6 and regulates IRS1 levels and insulin signaling in the skeletal muscle during diabetes

[21] Fukunaga T(2016)Long non-coding RNA H19 inhibits adipocyte differentiation of bone marrow mesenchymal stem cells through epigenetic modulation of histone deacetylases Sci Rep 6 659-4224

[22] Iwakiri J(2013)MicroRNA-22 (miR-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific Huntington's disease-related mechanisms PLoS ONE 8 82-1115

[23] Ono Y(2012)The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r Nat Cell Biol 14 31958-67

[24] Hamada M(2015)Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16 Mol Cancer 14 4065382-2111

[25] Gabory A(2020)A class I histone deacetylase inhibitor attenuates insulin resistance and inflammation in palmitate-treated C2C12 myotubes and muscle of HF/HFr diet mice Front Pharmacol 11 69-904

[26] Jammes H(2015)miR675 upregulates long noncoding RNA H19 through activating EGR1 in human liver cancer Oncotarget 6 233-530

[27] Dandolo L(2016)Histone acetylation and its modifiers in the pathogenesis of diabetic nephropathy J Diabetes Res 2016 46-736

[28] Gao J(2020)Long non-coding RNA H19 contributes to wound healing of diabetic foot ulcer J Mol Endocrinol 65 5810-9

[29] Gao Y(2000)Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases Mol Cell 6 1714-1554

[30] Geng T(2019)The lncRNA H19/miR-675 axis regulates myocardial ischemic and reperfusion injury by targeting PPARalpha Mol Immunol 105 4215-178

[21] Fukunaga T(2016)Long non-coding RNA H19 inhibits adipocyte differentiation of bone marrow mesenchymal stem cells through epigenetic modulation of histone deacetylases Sci Rep 6 659-4224

[22] Iwakiri J(2013)MicroRNA-22 (miR-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific Huntington's disease-related mechanisms PLoS ONE 8 82-1115

[23] Ono Y(2012)The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r Nat Cell Biol 14 31958-67

[24] Hamada M(2015)Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16 Mol Cancer 14 4065382-2111

[25] Gabory A(2020)A class I histone deacetylase inhibitor attenuates insulin resistance and inflammation in palmitate-treated C2C12 myotubes and muscle of HF/HFr diet mice Front Pharmacol 11 69-904

[26] Jammes H(2015)miR675 upregulates long noncoding RNA H19 through activating EGR1 in human liver cancer Oncotarget 6 233-530

[27] Dandolo L(2016)Histone acetylation and its modifiers in the pathogenesis of diabetic nephropathy J Diabetes Res 2016 46-736

[28] Gao J(2020)Long non-coding RNA H19 contributes to wound healing of diabetic foot ulcer J Mol Endocrinol 65 5810-9

[29] Gao Y(2000)Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases Mol Cell 6 1714-1554

[30] Geng T(2019)The lncRNA H19/miR-675 axis regulates myocardial ischemic and reperfusion injury by targeting PPARalpha Mol Immunol 105 4215-178